Propensity score methodology for confounding control in health care utilization databases

Epidemiology Biostatistics and Public Health

Volumn 10, Issue 3, 2013, Pages

  Patorno, Elisabetta ^a   Grotta, Alessandra ^b,c   Bellocco, Rino ^b,c   Schneeweiss, Sebastian ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Confounding; Epidemiologic methods; Health care databases; Non experimental studies; Propensity score

Indexed keywords

EID: 84884547429     PISSN: None     EISSN: 22820930     Source Type: Journal    
DOI: 10.2427/8940     Document Type: Article

References (92)

1. Arana A, Rivero E, Egberts TCG. What do we show and who does so? An analysis of the abstracts presented at the 19th ICPE. Pharmacoepidemiol Drug Saf. 2004; 13: S330-1.
2. Schneeweiss S, Avorn J. Using health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005; 58: 323-37.
3. Strom BL, Carson JL. Use of automated databases for Pharmacoepidemiology research. Epidemiol Rev. 1990; 12: 87-107.
4. Walker AM. Confounding by indication. Epidemiology. 1996; 7(4): 335-6.
5. Petri H, Urquhart J. Channeling bias in the interpretation of drug effects. Stat Med. 1991; 10(4): 577-81.
6. Walker AM. Observation and inference. An Introduction to the Methods of Epidemiology. Newton Lower Falls, MA: Epidemiology Resources Inc.; 1991: 119-28.
7. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005; 58(4): 323-37.
8. Brookhart MA, Sturmer T, Glynn RJ, et al. Confounding control in healthcare database research: challenges and potential approaches. Med Care 2010; 48(6 Suppl): S114-20.
9. Seeger JD, Kurth T, Walker AM. Use of propensity score technique to account for exposure related covariates: an example and lesson. Med Care. 2007; 45(Supl 2): S143-8.
10. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999 Jan; 10(1): 37-48.
11. Hernan MA, Robins JM. Causal Inference (Chapman & Hall/CRC, 2013). http://www.hsph.harvard.edu/miguelhernan/causal-inference-book/.
12. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996; 49(12): 1373-9.
13. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983; 70(1): 41-55.
14. Glynn RJ, Schneeweiss S, Stürmer T. Indications for Propensity Scores and Review of Their Use in Pharmacoepidemiology. Basic Clin Pharmacol Toxicol. 2006; 98(3): 253-9.
15. Setoguchi S, Schneeweiss S, Brookhart MA, et al. Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf 2008; 17: 546.5.
16. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a nonrandomized control group. Stat Med 1998; 17(19): 2265-81.
17. Braitman LE, Rosenbaum PR. Rare outcomes, common treatments: analytic strategies using propensity scores. Ann Intern Med 2002; 137: 693-5.
18. Joffe MM, Rosenbaum PR. Propensity Scores. American Journal of Epidemiology 1999; 150:327-33.
19. Rubin DB. Estimating causal effects from large data sets using the propensity score. Ann Intern Med 1997; 127: 757-63.
20. Brookhart MA, Schneeweiss S, Rothman KJ, et al. Variable selection for propensity score models. Am J Epidemiol. 2006; 163(12): 1149-56.
21. Myers JA, Rassen JA, Gagne JJ, et al. Effects of Adjusting for Instrumental Variables on Bias and Precision of Effect Estimates. Am J Epidemiol. 2011; 174(11): 1213-22.
22. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-83.
23. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993; 46: 1075-79, discussion 81-90.
24. Gagne JJ, Glynn RJ, Avorn J, et al. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011; 64(7): 749-59.
25. Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001; 154(9): 854-64.
26. Schneeweiss S, Rassen JA, Glynn RJ, et al. Highdimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009; 20(4): 512-22.
27. Anderson RM. Revisiting the behavioral model and access to medical care: Does it matter? J Health Social Behav. 1995; 36: 1-10.
28. Schneeweiss S, Glynn RJ, Avorn J, Solomon DH. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. J Clin Epidemiol. 2005; 58: 98-102.
29. Roblin DW, Platt R, Goodman MJ, et al. Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care. 2005; 43: 951-9.
30. Wooldridge, JM. Econometric Analysis of Cross Section and Panel Data. MIT Press; Cambridge, MA: 2001.
31. Greenland S. The effect of misclassification in the presence of covariates. Am J Epidemiol. 1980; 112: 564-9.
32. Greenland S, Robins JM. Confounding and misclassification. Am J Epidemiol. 1985; 122: 495-506.
33. Bross ID. Spurious effects from an extraneous variable. J Chronic Dis. 1966; 19(6): 637-47.
34. Rassen JA, Doherty M, Huang W, Schneeweiss S. Pharmacoepidemiology Toolbox. Boston, MA. http://www.hdpharmacoepi.org.
35. Arbogast PG, Kaltenbach L, Ding H, Ray WA. Adjustment for multiple cardiovascular risk factors using a summary risk score. Epidemiology. 2008; 19(1): 30-7.
36. Rassen JA, Glynn RJ, Brookhart MA, Schneeweiss S. Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol. 2011; 173(12): 1404-13.
37. Rassen JA, Schneeweiss S. Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system. Pharmacol Drug Saf. 2012; 21(S1): 41-9.
38. Stürmer T, Joshi M, Glynn RJ, et al. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol. 2006; 59(5): 437-47.
39. Schneeweiss S. A basic study design for expedited safety signal evaluation based on electronic healthcare data. Pharmacoepidemiol Drug Saf. 2010; 19: 858-68.
40. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. The American Statistician 1985; 39: 33-8.
41. Sturmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution - A Simulation Study. Am J Epidemiol 2010; 172: 843-54.
42. Rassen JA, Shelat AA, Myers JA, et al. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012; 21(S2): 69-80.
43. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Statist. Med. 2009; 28: 3083-3107.
44. Rassen JA, Shelat AA, Myers JA, Glynn RJ, Solomon DH, Schneeweiss S. Matching by Propensity Score in Cohort Studies with Three Treatment Groups. Epidemiology 2013; 24(3): 401-9.
45. Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behavioral Research 2011; 46: 399-424.
46. Hill J, Reiter JP. Interval estimation for treatment effects using propensity score matching. Statistics in Medicine 2006; 25: 2230-56.
47. Austin PC. Some Methods of Propensity-Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulations. Biometrical Journal 2009; 51: 171-84.
48. Parsons L. Reducing bias in a propensity score matchedpair sample using greedy matching techniques. In: Proceedings of the 26th Annual SAS User Group International Conference. SAS Institute Inc, 2001. http://www2.sas.com/proceedings/sugi26/p214-26.pdf. Accessed May 8, 2010.
49. Rosenbaum PR. Observational Studies. Springer-Verlag, New York:1995.
50. Ming K, Rosenbaum PR. Substantial Gains in Bias Reduction from Matching with a Variable Number of Controls. Biometric 2000; 56S: 118-24.
51. Austin PC. Statistical Criteria for Selecting the Optimal Number of Untreated Subjects Matched to Each Treated Subject When Using Many-to-One Matching on the Propensity Score. Am J Epidemiol 2010; 172: 1092-7.
52. Gu XS, Rosenbaum PR. Comparison of multivariate matching methods: Structures, distances, and algorithms. Journal of Computational and Graphical Statistics 1993; 2: 405-20.
53. Hansen BB. Full matching in an observational study of coaching for the SAT. Journal of the American Statistical Association 2004; 99: 609-18.
54. Rosenbaum PR. A characterization of optimal designs for observational studies. Journal of the Royal Statistical Society 1991; Series B 53: 597-610.
55. Austin PC. Assessing balance in measured baseline covariates when using many-to-one matching on the propensity-score. Pharmacoepidemiol Drug Saf. 2008; 17: 1218-25.
56. Imbens G. The role of the propensity score in estimating dose-response functions. Biometrika. 2000; 87: 706-10.
57. Cochran WG. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 1968; 24: 295-313.
58. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. Journal of the American Statistical Association 1984; 79: 516-24.
59. Huppler Hullsiek K, Louis TA. Propensity score modeling strategies for the causal analysis of observational data. Biostatistics 2002; 3: 179-93.
60. Kurth T, Walker AM, Glynn RJ, et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol. 2006; 163(3): 262-70.
61. Lunt M, Solomon D, Rothman K, et al. Different methods of balancing covariates leading to different effect estimates in the presence of effect modification. Am J Epidemiol. 2009; 169(7): 909-17.
62. van der Laan MJ, Rose S. Statistics ready for a revolution: next generation of statisticians must build tools for massive data sets. 2010 Amstat News.
63. Breiman L. Random forests. Machine Learning 2001; 45: 5-32.
64. Cross SS, Harrison RF, Kennedy RL. Introduction to neural networks. Lancet 1995; 346(8982): 1075-9.
65. Baxt WG. Application of artificial neural networks to clinical medicine. Lancet 1995; 346(8983): 1135-8.
66. Tibshirani R. Regression Shrinkage and Selection via the Lasso. Journal of the Royal Statistical Society 1996; Series B 58(1): 267-88.
67. Lee BK, Lessler J, Stuart EA. Improving propensity score weighting using machine learning. Statistics in Medicine 2010; 29: 337-46.
68. Lendle SD, Fireman B, van der Laan MJ. Targeted Maximum Likelihood Estimation in Safety Analysis. 2013; in press.
69. van der Laan MJ, Rose S. Targeted Learning: Causal Inference for Observational and Experimental Data. New York: Springer; 2011.
70. van der Laan MJ, Polley EC, Hubbard AE. Super learner. Statistical applications in genetics and molecular biology. 2007; 6(1): 1-21.
71. StataCorp. 2011. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP.
72. SAS Institute Inc. 2011. SAS 9.3. Cary, NC: SAS Institute, Inc.
73. R Development Core Team (2011). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org.
74. LaLonde R. Evaluating the Econometric Evaluations of Training Programs with Experimental Data. Am Econ Rev 1986; 76: 604-20.
75. Dehejia RH, Wahba S. Causal effects in non-experimental studies: Reevaluating the evaluation of training programs. J Am Statist Assoc 1999; 94: 1053-62.
76. Stuart EA. Matching methods for causal inference: a review and a look forward. Statist Sci 2010; 25(1): 1-21.
77. Yang G, Stemkowsky S, Saunders W. A review of propensity score application in healthcare outcome and epidemiology. Premier Inc. Working Paper PR02; 2007.
78. Leslie S, Thiebaud P. Using propensity scores to adjust for treatment selection bias. SAS Global Forum, Statistics and Data Analysis. Working Paper 184-2007.
79. Kleinman K, Horton NJ. Accessed May 28, 2013, at http://www.math.smith.edu/sasr.
80. Becker S, Ichino A. Estimation of average treatment effects based on propensity scores. The Stata Journal 2002; 2: 358-77.
81. Helmreich JE, Pruzek RM. PSAgraphics: An R package to support propensity score analysis. J Stat Softw 2009; 29(6): 1-23.
82. Ridgeway G, McCaffrey DF, Morral AR. Twang: Toolkit for weighting and analysis of nonequivalent groups. Software for using matching methods in R. 2006. Available at http://cran.rproject.org/src/contrib/ Descriptions/twang.html.
83. McCaffrey DF, Ridgeway G, Morral AR. Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods 2004; 9(4): 403-25.
84. Fang G, Brooks JM, Chrischilles EA. Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data. Am J Epidemiol 2012; 175(1): 60-5.
85. Caliendo M, Kopeinig S. Some practical guidance for the implementation of propensity score matching. J Econ Surv 2005; 22: 31-72.
86. Parsons LS. Performing a 1:N Case-Control Match on Propensity Score. Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference, Montreal, Canada. 2004.
87. Coca-Perraillon, M. Local and global optimal propensity score matching. SAS Global Forum, Statistics and Data Analysis. Working Paper 185-2007.
88. Feng W, Jun Y, Xu R. A Method/Macro Based on Propensity Score and Mahalanobis Distance to Reduce Bias in Treatment Comparison in Observational Study. SAS Technical Report 2006: 1-11. paper PR05.
89. Kosanke J, Bergstralh E. SAS Macro. Accessed May 28, 2013, at http://mayoresearch.mayo.edu/mayo/research/biostat/upload/vmatch.sas.
90. Leuven E, Sianesi B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing, Statistical Software Components S432001, Boston College Department of Economics. 2003.
91. Ho DE, Imai K, King G et al. MatchIt: Nonparametric preprocessing for parametric causal inference. J Stat Softw 2011; 42(8): 1-28.
92. Sekhon JS. Multivariate and propensity score matching software with automated balance optimization: the Matching package for R. J Stat Softw 2011; 42(7): 1-52